Skip to content

Emotion recognition during emotional arousal in patients with borderline personality disorder

Emotion recognition during emotional arousal in patients with borderline personality disorder - Emotion recognition in BPD

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON34608
Enrollment
78
Registered
2010-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Borderline personality disorder

Interventions

Emotional arousal is induced by the Trier Social Stress Test. This test consists of a motivated performance task, in which the participant has to prepare and deliver a free speech and perform mental
Simeon, Knutselska, Smith, Baker & Hollander, 2004). For further information see researchprotocol sections 7.3 and 10.4.

Sponsors

GGZ Groep Noord en Midden-Limburg
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: For patients: Borderline personality disorder all participants: only females between 18-45 yrs. IQ> 75

Exclusion criteria

Exclusion criteria: Substance abuse or other factors who influence cortisol levels or cognitive performance For BPD patients:psychotic disorder or bipolar disorder For healthy volunteers: Axis I or II disorders, history of psychiatric treatment or significant Axis I or II traits

Design outcomes

Primary

MeasureTime frame
Facial emotional recognition accuracy

Secondary

MeasureTime frame
To evaluate the success of inducing a state of arousal as measured by (manipulation check): Heart rate salivary hormone concentrations profile of mood states (POMS) to assess changes in affect during the experiment To evaluate whether personality traits or level of borderline symptomatology influence arousal conditions and emotion recognition accuracy self report questionnaires will be administered.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)